Dehydroepiandrosterone and related steroids alter 3T3-L1 preadipocyte proliferation and differentiation

Comparative Biochemistry and Physiology - C Pharmacology Toxicology and Endocrinology

Volumn 123, Issue 1, 1999, Pages 17-25

  Lea Currie, Y Renee ^a   Monroe, Dayle ^a   McIntosh, Michael K ^a  

^a Food Serv Syst Sch Hum E   (United States)

Author keywords

3T3 L1 preadipocytes; DHEA; Differentiation; Estrogens; Proliferation

Indexed keywords

ESTRADIOL; ESTRONE; GLYCEROL 3 PHOSPHATE DEHYDROGENASE; LIPID; PRASTERONE; PRASTERONE SULFATE; PREGNENOLONE; STEROID; TESTOSTERONE;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROADIPOCYTE;

3T3 CELLS; ADIPOSE TISSUE; ANIMALS; CELL COUNT; CELL DIFFERENTIATION; CELL DIVISION; DEHYDROEPIANDROSTERONE; DEHYDROEPIANDROSTERONE SULFATE; ESTROGENS; L CELLS (CELL LINE); MICE; TESTOSTERONE;

EID: 0033007987     PISSN: 07428413     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0742-8413(99)00003-1     Document Type: Article

References (63)

1. Berdanier C., McIntosh M. Further studies on the effects of DHEA on hepatic metabolism in BHE rats. Proc Soc Exp Biol Med. 192:1989;242-247.
2. Berdanier C., Parente J., McIntosh M. Is DHEA an antiobesity agent? FASEB J. 7:1993;414-419.
3. Cleary M., Hood S., Chando C., Hansen C., Billheimer J. Response of sucrose-fed rats to DHEA. Nutr Res. 4:1984;485-494.
4. Cleary M., Zabel T., Sartin J. Effects of short term DHEA treatment on serum and pancreatic insulin in Zucker rats. J Nutr. 118:1988;382-387.
5. Coleman D.L. Therapeutic effects of DHEA and its metabolites in diabetes - obesity mutants. Lardy H., Stratman F. Hormones, thermogenesis, and obesity. 1989;377-384 Elsevier, New York.
6. Darzynkiewicz Z., Juan G., Li X., Gorczyca W., Murakami T., Traganos F. Cytometry in cell necrobiology: Analysis of apoptosis and accidental cell death (necrosis). Cytometry. 27:1997;1-20.
7. DePergola G., Giagulli V., Garruti G., Cospite M., Giorgino F., Cignarelli M., Giorgino R. Low DHEA levels in premenopausal obese women with very high body mass index. Metabolism. 40:1991;187-190.
8. DePergola G., Triggiani V., Giorgino F., Cospite M., Garruti G., Cignarelli M., Guastamacchia E., Giorgino R. The free testosterone to DHEAS molar ratio as a marker of visceral fat accumulation in premenopausal obese women. Int J Obesity. 18:1994;659-664.
9. Desperes J., Tremblay A., Theriault G., Perusse L., LeBlanc C., Bouchard C. Relationships between body fatness, adipose tissue distribution and blood pressure in men and women. J Clin Epidemiol. 41:1988;889-897.
10. DiMonaco M., Pizzini A., Gatto V., Leonardi L., Gallo M., Brignardello E., Boccuzzi G. Role of glucose-6-phosphate dehydrogenase inhibition in the antiproliferative effects of dehydroepiandrosterone on human breast cancer cells. Br J Cancer. 75:1997;589-592.
11. Glascott P. Jr., Gilford E., Farber J. Effects of vitamin E on the killing of cultured hepatocytes by tertbutyl hydroperoxide. Mol Pharmacol. 41:1992;1155-1162.
12. Gordon G., Newitt J., Shantz L., Weng D., Talalay P. Inhibition of the conversion of 3T3-L1 fibroblast clones to adipocytes by dehydroepiandrosterone and related anticarcinogenic steroids. Cancer Res. 46:1986;3389-3395.
13. Haffner S., Valdez R. Decreased testosterone and DHEAS concentrations are associated with increased insulin and glucose concentrations in nondiabetic men. Metabolism. 43:1994;599-603.
14. Jakubowicz J., Beer N., Rengifo R. Effect of DHEA on c-GMP and body composition in men of advancing age. Ann NY Acad Sci. 774:1995;312-315.
15. James R., Krakower G., Kissebah A. Influence of androgenicity on adipocytes and precursor cells in female rats. Obesity Res. 4:1996;463-470.
16. Karp G. Cell and molecular biology. 1996;John Wiley & sons, New York.
17. Khalil M., Strutt B., Vachon D., Killinger D. Metabolism of dehydroepiandrosterone by cultured human adipose stromal cells. J Steroid Biochem Mol Biol. 46:1993;585-595.
18. Killinger D., Strutt B., Roncari D., Khalil W. Estrone formation from dehydroepiandrosterone in cultured human breast adipose stromal vascular cells. J Steroid Biochem Mol Biol. 52:1995;195-201.
19. Lardy H., Kneer N., Bellei M. Induction of thermogenic enyzmes by DHEA and its metabolites. Ann NY Acad Sci. 774:1995;171-179.
20. Lea-Currie R., Wu S., McIntosh M. Effects of acute administration of dehydroepiandrosterone sulfate on adipose tissue mass and cellularity in male rats. Int J Obesity. 21:1997;147-154.
21. Lea-Currie R., Wen P., McIntosh M. Dehydroepiandrosterone sulfate attenuates adipocyte hyperplasia associated with feeding rats a high fat diet. Int J Obesity. 21:1997;1058-1064.
22. Leiter E. Genes controlling tissue androgen/estrogen balance are primary modifiers of diabetes induced by obesity genes in mice. Nutrition. 4:1988;467-469.
23. MacDougald O., Lane D. Transcriptional regulation of gene expression during adipocyte differentiation. Ann Rev Biochem. 64:1995;345-373.
24. Marin P., Lonn L., Andersson B., Oden B., Olbe L., Bengtsson B., Bjorntorp P. Assimilation of triglycerides in subcutaneous and intra-abdominal adipose tissues in vivo in men: Effects of testosterone. J Clin Endocrinol Metab. 81:1996;1018-1022.
25. McGinnis J., Ballard R. Obesity in minority populations. Am J Clin Nutr. 53:1993;15125-15145.
26. McIntosh M., Berdanier C. Differential effects of adrenalectomy and starvation-refeeding on hepatic lipogenic responses to dehydroepiandrosterone and glucocorticoid in BHE and Sprague-Dawley rats. J Nutr. 118:1988;1011-1017.
27. McIntosh M., Berdanier C. Antiobesity effects of dehydroepiandrosterone are mediated by futile substrate cycling in the hepatocytes of BHE/cdb rats. J Nutr. 121:1991;2037-2043.
28. McIntosh M., Berdanier C. Influence of DHEA on the thyroid hormone status of BHE/cdb rats. J Nutr Biochem. 3:1992;194-199.
29. McIntosh M., Goldfarb A., Curtis L., Cote P. Vitamin E alters hepatic antioxidant enzymes in rats treated with dehydroepiandrosterone (DHEA). J Nutr. 123:1993;216-224.
30. McIntosh M., Goldfarb A., Cote P., Griffin K. Vitamin E reduces peroxisomal fatty acid oxidation and indicators of oxidative stress in exercised rats treated with DHEA. J Nutr Biochem. 4:1993;298-303.
31. McIntosh M., Hausman D., Martin R., Hausman G. Dehydroepiandrosterone (DHEA) attenuates preadipocyte proliferation and differentiation in primary cultures of stromal-vascular cells. FASEB J. 11:1997;158.
32. Mohan P., Ihnen J., Levin B., Cleary M. Effect of DHEA treatments with diet-induced obesity. J Nutr. 120:1990;1103-1114.
33. Morales A., Nolan J., Nelson J., Yen S. Effects of replacement dose of DHEA in men and women of advancing age. J Clin Endocrinol Metab. 78:1994;1360-1367.
34. Nakashima N., Haji M., Sakai Y., Ono Y., Umeda F., Nawata H. Effect of dehydroepiandrosterone on glucose uptake in cultured human fibroblasts. Metabolism. 44:1995;543-548.
35. Nakashima N., Haji M., Umeda F., Nawata H. Effect of dehydroepiandrosterone on glucose uptake in cultured rat myoblasts. Horm Metab Res. 27:1995;491-494.
36. Nestler J., Barlascini C., Clore J., Blackard W. DHEA reduces serum LDL levels and body fat but does not alter insulin sensitivity in older men. J Clin Endocrinol Metab. 66:1988;57-61.
37. Nestler J., Clore J., Blackard W. Metabolism and actions of dehydroepiandrosterone in humans. J Steroid Biochem Mol Biol. 40:1991;599-605.
38. Nestler J., Clore J., Blackard W. Dehydroepiandrosterone: The missing link between hyperinsulinemia and atherosclerosis. FASEB J. 6:1992;3073-3075.
39. NHANES III. Plan and operation of the Health and Nutrition Examination survey, 1988-94. Hyattsville, MD: DHHS (PHS), NCHS (Vital and health statistics), 1995.
40. Nishio E., Tomiyama K., Nakata H., Watanabe Y. 3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitor impairs cell differentiation in cultured adipogenic cells (3T3-L1). Eur J Pharmacol. 301:1996;203-206.
41. Orentreich N., Brind J., Rizer R., Vogelman J. Age changes and sex differences in serum DHEA-sulfate concentrations throughout adulthood. J Clin Endocrinol Metab. 59:1985;551-555.
42. Pashko L., Schwartz A. Antihyperglycemic effect of dehydroepiandrosterone analogue 16-fluoro-5-androsten-17-one in diabetic mice. Diabetes. 42:1995;1105-1108.
43. Pendersen S., Bofglum J., Eriksen E., Richelsen B. Nuclear estradiol binding in rat adipocytes. Regional variations and regulatory influences of hormones. Biochim Biophys Acta. 1093:1991;80-86.
44. Phillips M., Enam E., Liu P., Matsumura F. Inhibition of 3T3-L1 adipose differentiation by 2,3,7,8-tetrachlorodibenzo-p-dioxin. J Cell Sci. 108:1995;395-402.
45. Prins J., O'Rahilly S. Regulation of adipose cell number in man. Clin Sci. 92:1997;3-11.
46. Rebuffe-Scrive M., Marin P., Bjorntorp P. Effect of testosterone on abdominal adipose tissue in men. Int J Obesity. 15:1991;791-795.
47. Reuter S., Mayer D. Transport of DHEA and DHEAS into rat hepatocytes. J Steroid Biochem Mol Biol. 54:1995;227-235.
48. Roncari D., Van R. Promotion of human adipocyte precursor replication by 17beta-estradiol in culture. J. Clin. Invest. 62:1978;503-508.
49. Schmidt R., Glomset J., Wight T., Habenicht A., Ross R. A study of the influence of mevalonic acid and its metabolites on the morphology of swiss 3T3 cells. J Cell Biol. 95:1982;144-153.
50. Schultz S., Klann R., Schonfeld S., Nyce J. Mechanism of cell growth and inhibition and cell cycle arrest in human colonic adenocarcinoma cells by dehydroepiandrosterone: Role of isoprenoid biosynthesis. Cancer Res. 52:1992;1372-1376.
51. Schwartz A., Whitcomb J., Nyce J., Lewbart M., Pashko L. Dehydroepiandrosterone and structural analogs: A new class of cancer chemopreventive agents. Adv Cancer Res. 51:1988;391-423.
52. Shantz L., Talalay P., Gordon G. Mechanism of inhibition of growth of 3T3-L1 fibroblasts and their differentiation to adipocytes by dehydroepiandrosterone and related steroids: role of glucose-6-phosphate dehydrogenase. Proc Natl Acad Sci USA. 86:1989;3852-3856.
53. Simpson E., Ackerman G., Smith M., Mendelson C. Estrogen formation in stromal cells of adipose tissue of women: Induction by glucocorticoids. Proc Natl Acad Sci USA. 78:1981;5690-5694.
54. Tagliaferro A., Davis J., Truchon S., Van Hamont N. Effects of dehydroepiandrosterone acetate on metabolism, body weight, and composition of male and female rats. J Nutr. 116:1986;1977-1983.
55. Tagliaferro A., Ronan A., Payne J., Meeker L., Tse S. Increased lipolysis to beta-adrenergic stimulation after dehydroepiandrosterone treatment in rats. Am J Physiol. 268:1995;1374-1380.
56. Vermeulen A., Kaufman J., Giagulli V. Influence of some biological indexes of sex hormone-binding globulin and androgen levels in aging or obese males. J Clin Endocrinol Metab. 81:1996;1821-1826.
57. Vigano T., Hernandez A., Corsini A., Granata A., Belloni P., Fumagalli R., Paoletti R., Folco G. Mevalonate pathway and isoprenoids regulated human bronchial myocyte proliferation. Eur J Pharmacol. 291:1995;201-203.
58. Wang T., Hursting S., Perkins S., Phang J. Effects of dehydroepiandrosterone and calorie restriction on the Bcl/Bax mediated apoptotic pathway in p53 deficient mice. Cancer Lett. 116:1997;61-69.
59. Wen P., Lea-Currie R., Alexander E., McIntosh M. Dehydroepiandrosterone reduces proliferation and differentiation of 3T3-L1 preadipocytes. FASEB J. 11:1997;158.
60. Wise L., Green H. Participation of one isozyme of cytosolic glycerophosphate dehydrogenase in the adipose conversion of 3T3 cell. J Biol Chem. 254:1979;273-275.
61. Yamada J., Sakuma M., Suga T. Induction of peroxisomal B-oxidation enzymes by dehydroepiandrosterone and its sulfate in primary cultures of rat hepatocytes. Biochim Biophys Acta. 1137:1992;231-236.
62. Yen T., Allan J., Pearson D., Acton J., Greenberg M. Prevention of obesity in Avy/a mice by dehydroepiandrosterone. Lipids. 12:1971;409-413.
63. Yen S., Morales A., Khorram O. Replacement of DHEA in aging men and women. Potential remedial effects. Ann NY Acad Sci. 774:1995;128-142.